Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis

Clinical trial NCT06342466 · RECRUITING

Trial details

NCT number: NCT06342466
Sponsor: Jin Lu, MD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Amyloidosis

Start date: 2024-05-06
Primary completion: 2026-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.